Literature DB >> 10959032

Oxidative processes in Alzheimer's disease: the role of abeta-metal interactions.

T Lynch1, R A Cherny, A I Bush.   

Abstract

Alzheimer's disease is characterized by signs of a major oxidative stress in the neocortex and the concomitant deposition of Amyloid beta (Abeta). Abeta is a metalloprotein that binds copper, and is electrochemically active. Abeta converts molecular oxygen into hydrogen peroxide by reducing copper or iron, and this may lead to Fenton chemistry. Hydrogen peroxide is a freely permeable prooxidant that may be responsible for many of the oxidative adducts that form in the Alzheimer-affected brain. The electrochemical activity of various Abeta species correlates with the peptides' neurotoxicity in cell culture, and participation in the neuropathology of Alzheimer's disease. These reactions present a novel target for Alzheimer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10959032     DOI: 10.1016/s0531-5565(00)00112-1

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  34 in total

1.  Lens defects and age-related fiber cell degeneration in a mouse model of increased AbetaPP gene dosage in Down syndrome.

Authors:  Peter H Frederikse; Xiao-Ou Ren
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases.

Authors:  Maria Valeria Catani; Valeria Gasperi; Tiziana Bisogno; Mauro Maccarrone
Journal:  Antioxid Redox Signal       Date:  2017-07-24       Impact factor: 8.401

3.  The plasma membrane redox system is impaired by amyloid β-peptide and in the hippocampus and cerebral cortex of 3xTgAD mice.

Authors:  Dong-Hoon Hyun; Mohamed R Mughal; Hyunwon Yang; Ji Hyun Lee; Eun Joo Ko; Nicole D Hunt; Rafael de Cabo; Mark P Mattson
Journal:  Exp Neurol       Date:  2010-07-27       Impact factor: 5.330

4.  Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging.

Authors:  Hani Atamna; David W Killilea; Alison Nisbet Killilea; Bruce N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

5.  A reduced zinc diet or zinc transporter 3 knockout attenuate light induced zinc accumulation and retinal degeneration.

Authors:  Shi Bai; Carolyn R Sheline; Yongdong Zhou; Christian T Sheline
Journal:  Exp Eye Res       Date:  2012-12-26       Impact factor: 3.467

Review 6.  Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.

Authors:  M P Mattson; S L Chan
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

Review 7.  Oxidative stress and β-amyloid protein in Alzheimer's disease.

Authors:  Zhiyou Cai; Bin Zhao; Anna Ratka
Journal:  Neuromolecular Med       Date:  2011-09-08       Impact factor: 3.843

8.  Timosaponin B-II ameliorates scopolamine-induced cognition deficits by attenuating acetylcholinesterase activity and brain oxidative damage in mice.

Authors:  Xu Zhao; Chunmei Liu; Yu Qi; Lina Fang; Jie Luo; Kaishun Bi; Ying Jia
Journal:  Metab Brain Dis       Date:  2016-07-22       Impact factor: 3.584

9.  Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease.

Authors:  Gang Liu; Ping Men; George Perry; Mark A Smith
Journal:  J Nanoneurosci       Date:  2009-06-01

10.  Conserved rhodopsin intradiscal structural motifs mediate stabilization: effects of zinc.

Authors:  Scott Gleim; Aleksandar Stojanovic; Eric Arehart; Daniel Byington; John Hwa
Journal:  Biochemistry       Date:  2009-03-03       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.